ADXS

Ayala Pharmaceuticals (PK) (ADXS)

Ayala Pharmaceuticals Inc (PK)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:USOTC:ADXS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/03/06	21:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/03/06	06:30	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/03/05	22:16	Edgar (US Regulatory)	Form DEFM14C - Definitive information statement relating to merger or acquisition	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/02/24	06:30	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/02/21	07:22	Edgar (US Regulatory)	Form PREM14C - Preliminary information statements relating to merger or acquisition	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/02/15	06:26	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/02/13	04:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/02/13	01:58	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/02/12	22:27	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/02/10	07:15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/02/06	22:51	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/01/04	06:18	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/21	23:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/21	23:00	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/20	23:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/16	06:04	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/09	06:01	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/04	00:46	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/04	00:45	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/04	00:43	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/03	05:05	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/10/31	20:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/10/31	20:05	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/10/23	19:45	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/10/23	19:45	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/10/23	19:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/10/23	19:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/10/21	05:31	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/09/29	19:13	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/09/29	19:10	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)